Your browser doesn't support javascript.
loading
Rational Design of Hybrid Peptides: A Novel Drug Design Approach.
Wang, Chao; Yang, Chen; Chen, Yu-Chen; Ma, Liang; Huang, Kun.
Afiliação
  • Wang C; School of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.
  • Yang C; School of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.
  • Chen YC; School of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.
  • Ma L; School of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.
  • Huang K; School of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China. kunhuang@hust.edu.cn.
Curr Med Sci ; 39(3): 349-355, 2019 Jun.
Article em En | MEDLINE | ID: mdl-31209802
ABSTRACT
Peptides play crucial roles in various physiological and pathological processes. Consequently, the investigation of peptide-based drugs is a highlight in the research and development of new drugs. However, natural peptides are not always ideal choices for clinical application due to their limited number and sometimes cytotoxicity to normal cells. Aiming to gain stronger or specific or novel biological effects and overcome the disadvantages of natural peptides, artificial hybrid peptides have been designed by combining the sequence of two or more different peptides with varied biological functions. Compared to natural peptides, hybrid peptides have shown better therapeutic potentials against bacteria, tumors, and metabolic diseases. In this review, design strategies, structure features and recent development of hybrid peptides are summarized; future directions for the research and development of hybrid peptide drugs are also discussed.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Recombinantes de Fusão / Engenharia de Proteínas / Peptídeos Catiônicos Antimicrobianos / Peptídeos Penetradores de Células / Hipoglicemiantes / Antineoplásicos Limite: Humans Idioma: En Revista: Curr Med Sci Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Recombinantes de Fusão / Engenharia de Proteínas / Peptídeos Catiônicos Antimicrobianos / Peptídeos Penetradores de Células / Hipoglicemiantes / Antineoplásicos Limite: Humans Idioma: En Revista: Curr Med Sci Ano de publicação: 2019 Tipo de documento: Article